Stay updated with breaking news from Robert Ajer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Parallel Advisors LLC trimmed its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 17.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,215 shares of the biotechnology company’s stock after selling 262 shares during […]
AdvisorNet Financial Inc lifted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 18.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,950 shares of the biotechnology company’s stock after acquiring an additional 1,418 shares during the […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Equities analysts expect BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) to report sales of $515.44 million for the current quarter, Zacks reports. Ten analysts have issued estimates for BioMarin Pharmaceutical’s earnings, with the lowest sales estimate coming in at $495.84 million and the highest estimate coming in at $545.45 million. BioMarin Pharmaceutical reported sales of […]
J.W. Cole Advisors Inc. cut its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 39.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,950 shares of the biotechnology company’s stock after selling 1,950 shares during the quarter. J.W. Cole Advisors Inc.’s […]